Summary
Among Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus the relationships between glycated haemoglobin (HbA1), fasting or 2-h post-load plasma glucose and diabetic retinopathy were examined by cross-sectional and prospective analyses, and the strengths of the associations were directly compared by receiver operating characteristic analysis. In the cross-sectional analysis, HbA1, fasting and 2-h plasma glucose were each significantly related to retinopathy among 789 diabetic subjects by separate logistic models. In a stepwise multiple logistic model in which HbA1, fasting and 2-h plasma glucose were included, HbA1 was selected as having the strongest association with retinopathy and neither fasting nor 2-h plasma glucose contributed significantly to the model once HbA1 was entered. Similarly, in the prospective analysis, HbA1, fasting and 2-h plasma glucose all predicted retinopathy in 227 diabetic subjects by separate proportional-hazards models. In a stepwise proportional-hazards model with HbA1, fasting and 2-h plasma glucose available to the model, HbA1 was again selected as having the strongest association with the incidence of retinopathy, and neither fasting nor 2-h plasma glucose significantly added to the prediction of retinopathy. A receiver operating characteristic analysis was used to determine if HbA1 was statistically significantly better than fasting or 2-h plasma glucose in assessing the risk for retinopathy. In neither the cross-sectional nor the prospective data did the area under the receiver operating characteristic curve for HbA1 differ significantly from that for fasting or 2-h plasma glucose (p>0.05 for each). In conclusion, HbA1, an integrated measure of blood glucose concentration over a period of 2–3 months, is slightly more closely associated with the prevalence and incidence of diabetic retinopathy than a single blood glucose determination. However, the differences between HbA1 and fasting or 2-h plasma glucose in assessing the association with or the risk for retinopathy are not significant.
Article PDF
Similar content being viewed by others
References
Little RR, England JD, Weidmeyer H et al. (1988) Relationship of glycosylated hemoglobin to oral glucose tolerance: implications for diabetes screening. Diabetes 37: 60–64
Compagnucci P, Cartechini MG, Bolli G, Feo PD, Santeusanio F, Brunetti P (1981) The importance of determining irreversibly glycosylated hemoglobin in diabetics. Diabetes 30: 607–612
Bunn HF (1981) Evaluation of glycosylated hemoglobin in diabetic patients. Diabetes 30: 613–617
Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1988) Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260: 2864–2871
Janka HU, Warram JH, Rand LI, Krolewski A (1989) Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 38: 460–464
Kalter-Leibovici O, Dyk DJV, Leibovici L et al. (1991) Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes 40: 204–210
Nathan DM, Singer DE, Godine JE, Harrington CH, Perlemuter LC (1986) Retinopathy in older type II diabetes: association with glucose control. Diabetes 35: 797–801
Teuscher A, Schnell H, Wilson PWF (1988) Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 11: 246–251
Knowler WC, Bennett PH, Ballintine EJ (1980) Increased incidence of retinopathy in diabetics with elevated blood pressure: a six-year follow-up study in Pima Indians. N Engl J Med 302: 645–650
Pettitt DJ, Knowler WC, Lisse JR, Bennett PH (1980) Development of retinopathy and proteinuria in relation to plasma glucose concentrations in Pima Indians. Lancet II: 1050–1052
West KM, Erdreich LJ, Stober JA (1980) A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 29: 501–508
Dorf A, Ballintine EJ, Bennett PH, Miller M (1976) Retinopathy in Pima Indians: relationships to glucose level, duration of diabetes, age at diagnosis of diabetes, and age at examination in a population with a high prevalence of diabetes mellitus. Diabetes 225: 554–560
Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, Kahn CR (1986) Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care 9: 443–452
Ballard DJ, Melton LJ III, Dwyer MS et al. (1986) Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 9: 334–342
Bennett PH, Burch TA, Miller M (1971) Diabetes mellitus in American (Pima) Indians. Lancet II: 125–128
Diabetes mellitus (1985) Report of a WHO Study Group. WHO Technical Report Series 727. Geneva, World Health Organization, pp 9–17
Menard L, Dempsey ME, Blankstein LA, Aleyassine H, Wacks M, Soeldner JS (1980) Quantitative determination of glycosylated hemoglobin A1 by agar gel electrophoresis. Clin Chem 26: 1598–1602
Hayes EJ, Gleason RE, Soeldner JS, Wacks M, Blankstein L (1981) Measurement of hemoglobin A1 by liquid chromatography and by agar gel electrophoresis compared. Clin Chem 27: 476–479
Diabetic Retinopathy Study Research Group (1981) A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21: 210–226
Klein R, Klein BEK, Magli YL et al. (1986) An alternative method of grading diabetic retinopathy. Ophthalmology 93: 1183–1187
Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29–36
Metz CE, Wang PL, Kronman HB (1984) A new approach for testing the significance of differences between ROC curves measured from correlated data. In: Deconinck F (ed) Proceedings of the VIIIth Conference on Information Processing in Medical Imaging. M Nijoff, The Hague, pp 432–445
Nelson RG, Wolfe JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC (1989) Proliferative retinopathy in NIDDM: incidence and risk factors in Pima Indians. Diabetes 38: 435–440
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, Q.Z., Pettitt, D.J., Hanson, R.L. et al. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia 36, 428–432 (1993). https://doi.org/10.1007/BF00402279
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00402279